Section Arrow
ANRO.NYSE
- Alto Neuroscience
Quotes are at least 15-min delayed:2026/09/21 23:53 EDT
Regular Hours
Last
 30.63
+0.36 (+1.19%)
Day High 
30.81 
Prev. Close
30.27 
1-M High
37.48 
Volume 
357.80K 
Bid
28.9
Ask
30.95
Day Low
29.8 
Open
30.64 
1-M Low
29.8673 
Market Cap 
1.19B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 32.23 
20-SMA 34.04 
50-SMA 30.91 
52-W High 37.48 
52-W Low 3.65 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-2.32/-3.87
Enterprise Value
1.21B
Balance Sheet
Book Value Per Share
5.59
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.97+0.14+3.66%-- 
MRNAModerna172.94+18.9+12.27%-- 
SLXNSilexion Therapeutics Corp.0.5441+0.1086+24.94%-- 
CELZCreative Medical Technology Holdings1.005+0.0391+4.05%-- 
PDSBPDS Biotechnology Corp0.8419+0.0364+4.52%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.